NASDAQ
WINT

Windtree Therapeutics Inc

(NO DISGNOSTIC SUBSTANCES)
LIFE SCIENCES

Prices are adjusted according to historical splits.

Windtree Therapeutics Inc Stock Price

Vitals

Today's Low:
$0.1640
Today's High:
$0.1845
Open Price:
$0.1750
52W Low:
$0.16
52W High:
$1.85
Prev. Close:
$0.1723
Volume:
550560

Company Statistics

Market Cap.:
$0.005 billion
Book Value:
0.653
Revenue TTM:
$0.000 billion
Operating Margin TTM:
0%
Gross Profit TTM:
$-0.018 billion
Gross Profit TTM:
$-0.018 billion
Profit Margin:
0%
Return on Assets TTM:
-25.4%
Return on Equity TTM:
-123.1%

Company Profile

Windtree Therapeutics Inc had its IPO on 2016-01-04 under the ticker symbol WINT.

The company operates in the LIFE SCIENCES sector and (NO DISGNOSTIC SUBSTANCES) industry. Windtree Therapeutics Inc has a staff strength of 0 employees.

Stock update

Shares of Windtree Therapeutics Inc opened at $0.18 at the start of the last trading session i.e. 2022-11-02.

The stocks traded within a range of $0.16 - $0.18, and closed at $0.16.

This is a -4.82% slip from the previous day's closing price.

A total volume of 550,560 shares were traded at the close of the day’s session.

In the last one week, shares of Windtree Therapeutics Inc have increased by 0%.

Windtree Therapeutics Inc's Key Ratios

Windtree Therapeutics Inc has a market cap of $0.005 billion, indicating a price to book ratio of 0.287 and a price to sales ratio of 660.53.

In the last 12-months Windtree Therapeutics Inc’s revenue was $0.000 billion with a gross profit of $-0.018 billion and an EBITDA of $-0.029 billion. The EBITDA ratio measures Windtree Therapeutics Inc's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Windtree Therapeutics Inc’s operating margin was 0% while its return on assets stood at -25.4% with a return of equity of -123.1%.

In Q2, Windtree Therapeutics Inc’s quarterly earnings growth was a positive 0% while revenue growth was a negative 100%.

Windtree Therapeutics Inc’s PE and PEG Ratio

Forward PE
-
Trailing PE
-
PEG
0

Its diluted EPS in the last 12-months stands at $-2.437 per share while it has a forward price to earnings multiple of - and a PEG multiple of 0. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Windtree Therapeutics Inc’s profitability.

Windtree Therapeutics Inc stock is trading at a EV to sales ratio of 706.08 and a EV to EBITDA ratio of 0.0542. Its price to sales ratio in the trailing 12-months stood at 660.53.

Windtree Therapeutics Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets
$0.000 billion
Total Liabilities
$0.000 billion
Operating Cash Flow
$0.000 billion
Capital Expenditure
$0.000 billion
Dividend Payout Ratio
0%

Windtree Therapeutics Inc ended 1970 with $0.000 billion in total assets and $131.2 billion in total liabilities. Its intangible assets were valued at $0.000 billion while shareholder equity stood at $0.000 billion.

Windtree Therapeutics Inc ended 1970 with $0.000 billion in deferred long-term liabilities, $0.000 billion in other current liabilities, billion in common stock, $0.000 billion in retained earnings and $0.000 billion in goodwill. Its cash balance stood at $0.000 billion and cash and short-term investments were $0.000 billion. The company’s total short-term debt was $0.000 billion while long-term debt stood at $0.000 billion.

Windtree Therapeutics Inc’s total current assets stands at $0.000 billion while long-term investments were $0.000 billion and short-term investments were $0.000 million. Its net receivables were $0.000 billion compared to accounts payable of $0.000 billion and inventory worth $0.000 billion.

In 1970, Windtree Therapeutics Inc's operating cash flow was $0.000 billion while its capital expenditure stood at $0.000 billion.

Comparatively, Windtree Therapeutics Inc paid $0 billion in dividends in 1970.

Other key metrics

Current Trading Price
$0.16
52-Week High
$1.85
52-Week Low
$0.16
Analyst Target Price
$3

Windtree Therapeutics Inc stock is currently trading at $0.16 per share. It touched a 52-week high of $1.85 and a 52-week low of $1.85. Analysts tracking the stock have a 12-month average target price of $3.

Its 50-day moving average was $0 and 200-day moving average was $0 The short ratio stood at indicating a short percent outstanding of 0%.

Around 0% of the company’s stock are held by insiders while 0% are held by institutions.

Frequently Asked Questions About Windtree Therapeutics Inc

The stock symbol (also called stock or share ticker) of Windtree Therapeutics Inc is WINT

The IPO of Windtree Therapeutics Inc took place on 2016-01-04

Similar Industry Stocks ((NO DISGNOSTIC SUBSTANCES))

Last Price
Chg
Chg%
$20.01
0
0%
$0.35
-0
-0.4%
$1.3
-0.07
-5.11%
$3.51
-0.04
-1.13%
Moderna Inc (MRNA)
$148.62
-6
-3.88%

Most Active

Last Price
Chg
Chg%
$58.63
-1.03
-1.73%
$92.12
-4.67
-4.82%
$5.12
-0.61
-10.65%
Apple Inc (AAPL)
$145.03
-5.62
-3.73%
$0.06
0.01
+12.74%

Top Gainers

Last Price
Chg
Chg%
$73
42.7
+140.92%
Oi S.A (OIBR-C)
$0
0
+100%
$0.02
0.01
+100%
$0.25
0.1
+66.44%
$2.85
1.01
+54.86%

Top Losers

Last Price
Chg
Chg%
$5.36
-22.58
-80.82%
$0.02
-0.06
-78.67%
Air T, Inc (AIRTW)
$0.01
-0.03
-75%
$4.51
-5.17
-53.41%
$11.5
-12.2
-51.48%

About

Windtree Therapeutics, Inc., a clinical-stage biotechnology and medical device company, focuses on the development of therapies for the treatment of acute pulmonary and cardiovascular diseases.

Address

2600 KELLY ROAD, SUITE 100, WARRINGTON, PA, US